logo

For the Inventor, By the Inventor

Lambertville, NJ, United States of America

Martin F Haslanger

This inventor holds 52 USPTO granted patents, plus 3 CIPO patents, primarily in Prostaglandin Analogues (CPC class 5145). Top assignees: E. R. Squibb Sons, Inc., Schering Corporation. Active years: 1980-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin F Haslanger. Retrieved from https://idiyas.com/inventor/martin-f-haslanger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.1

ph-index = 15

Forward Citations = 682(Granted Patents)

Forward Citations (Not Self Cited) = 673(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Lambertville, NJ (US) (1980 - 1987)
  • Ridgewood, NJ (US) (1988 - 1993)
  • Carmel, IN (US) (1995)

Company Filing History:

goldMedal45 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents
silverMedal7 out of 1,829 
 
Schering Corporation
 patents

Years Active: 1980-1995

Loading Chart...
Loading Chart...
Areas of Expertise:
Prostaglandin Analogues
Antihypertensives
Hydroxamic Acids
Carboxyalkylcarbonyl
Amino Acids
Mercapto-Acylamino
Phenyl Hydroxamic
7-Oxabicycloheptane
Neutral Metalloendopeptidase
Thrombolytic Agents
Aryl Substituted
Cardiovascular Agents
52 patents (USPTO):Explore Patents
1. 5389610 - Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors (1995-02-14),
2. 5262436 - Acylamino acid antihypertensives in the treatment of congestive heart (1993-11-16),
3. 5061710 - Mercapto-acylamino acid antihypertensives (1991-10-29),
4. 4929641 - Mercapto-acylamino acid antihypertensives (1990-05-29),
5. 4921941 - Orally active antiandrogens (1990-05-01),
6. 4906667 - Phenyl hydroxamic acids including a hetero-containing substituent (1990-03-06),
7. 4889874 - Hydroxamic acid derivatives and method of using same (1989-12-26),
8. 4801609 - Mercapto-acylamino acid antihypertensives (1989-01-31),
9. 4749688 - Use of neutral metalloendopeptidase inhibitors in the treatment of (1988-06-07),
10. 4728670 - Biphenyl hydroxamic acids (1988-03-01),
11. 4661506 - 7-oxabicycloheptane substituted ox prostaglandin analogs (1987-04-28),
12. 4614825 - 7-oxabicycloheptane and 7-oxabicycloheptene compounds (1986-09-30),
13. 4607053 - Arylhydroxamates useful as antiallergy agents (1986-08-19),
14. 4604407 - Hydroxamates (1986-08-05),
15. 4588743 - 7-oxabicycloheptane-substituted oxa prostaglandin analogs and their use (1986-05-13),

Title: The Innovative Mind of Martin F Haslanger

Introduction: Martin F Haslanger, a distinguished inventor hailing from Lambertville, NJ, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Martin F Haslanger's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device aimed at improving patient outcomes in the healthcare industry.

Career Highlights: With a career spanning over two decades, Martin F Haslanger has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only garnered critical acclaim but has also positively impacted numerous industries.

Collaborations: Throughout his career, Martin F Haslanger has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Martin F Haslanger's relentless pursuit of innovation and his passion for creating solutions to real-world problems have solidified his position as a prominent figure in the world of inventors. His dedication to pushing the boundaries of technology continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…